Stifel Financial’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-11,601
| Closed | -$219K | – | 3429 |
|
|
2023
Q2 | $219K | Sell |
11,601
-16,912
| -59% | -$200K | ﹤0.01% | 2994 |
|
|
2023
Q1 | $109K | Buy |
28,513
+394
| +1% | +$1.68K | ﹤0.01% | 3169 |
|
|
2022
Q4 | $139K | Sell |
28,119
-63,477
| -69% | -$344K | ﹤0.01% | 3075 |
|
|
2022
Q3 | $438K | Sell |
91,596
-22,838
| -20% | -$120K | ﹤0.01% | 2506 |
|
|
2022
Q2 | $516K | Buy |
114,434
+3,050
| +3% | +$13.3K | ﹤0.01% | 2446 |
|
|
2022
Q1 | $530K | Buy |
111,384
+4,962
| +5% | +$27.5K | ﹤0.01% | 2544 |
|
|
2021
Q4 | $791K | Buy |
106,422
+18,500
| +21% | +$115K | ﹤0.01% | 2294 |
|
|
2021
Q3 | $498K | Buy |
87,922
+3,607
| +4% | +$20.8K | ﹤0.01% | 2577 |
|
|
2021
Q2 | $555K | Sell |
84,315
-2,376
| -3% | -$16.6K | ﹤0.01% | 2525 |
|
|
2021
Q1 | $703K | Sell |
86,691
-10,108
| -10% | -$82.5K | ﹤0.01% | 2254 |
|
|
2020
Q4 | $624K | Sell |
96,799
-25,215
| -21% | -$147K | ﹤0.01% | 2176 |
|
|
2020
Q3 | $439K | Buy |
122,014
+6,749
| +6% | +$27.2K | ﹤0.01% | 2166 |
|
|
2020
Q2 | $530K | Sell |
115,265
-2,471
| -2% | -$10.5K | ﹤0.01% | 2007 |
|
|
2020
Q1 | $320K | Sell |
117,736
-1,980
| -2% | -$8.66K | ﹤0.01% | 2138 |
|
|
2019
Q4 | $538K | Sell |
119,716
-67,534
| -36% | -$229K | ﹤0.01% | 2208 |
|
|
2019
Q3 | $370K | Sell |
187,250
-2,267
| -1% | -$6.02K | ﹤0.01% | 2326 |
|
|
2019
Q2 | $320K | Buy |
189,517
+59,667
| +46% | +$141K | ﹤0.01% | 2464 |
|
|
2019
Q1 | $272K | Buy |
129,850
+25,703
| +25% | +$111K | ﹤0.01% | 2421 |
|
|
2018
Q4 | $412K | Buy |
104,147
+19,988
| +24% | +$121K | ﹤0.01% | 2045 |
|
|
2018
Q3 | $717K | Buy |
84,159
+2,311
| +3% | +$22.2K | ﹤0.01% | 1898 |
|
|
2018
Q2 | $721K | Sell |
81,848
-3,278
| -4% | -$34.6K | ﹤0.01% | 1824 |
|
|
2018
Q1 | $839K | Sell |
85,126
-52,931
| -38% | -$523K | ﹤0.01% | 1686 |
|
|
2017
Q4 | $836K | Buy |
138,057
+23,366
| +20% | +$144K | ﹤0.01% | 1628 |
|
|
2017
Q3 | $873K | Buy |
114,691
+3,213
| +3% | +$21.3K | ﹤0.01% | 1561 |
|
|
2017
Q2 | $791K | Buy |
111,478
+7,663
| +7% | +$35.1K | ﹤0.01% | 1588 |
|
|
2017
Q1 | $382K | Buy |
103,815
+12,907
| +14% | +$37.7K | ﹤0.01% | 1967 |
|
|
2016
Q4 | $174K | Buy |
90,908
+31,549
| +53% | +$63.3K | ﹤0.01% | 2290 |
|
|
2016
Q3 | $154K | Sell |
59,359
-10,826
| -15% | -$31.5K | ﹤0.01% | 2244 |
|
|
2016
Q2 | $217K | Sell |
70,185
-1,804
| -3% | -$11.3K | ﹤0.01% | 2218 |
|
|
2016
Q1 | $611K | Buy |
71,989
+659
| +0.9% | +$5.58K | ﹤0.01% | 1475 |
|
|
2015
Q4 | $968K | Buy |
71,330
+47,999
| +206% | +$591K | 0.01% | 1323 |
|
|
2015
Q3 | $225K | Sell |
23,331
-6,989
| -23% | -$102K | ﹤0.01% | 1964 |
|
|
2015
Q2 | $385K | Buy |
+30,320
| New | +$333K | ﹤0.01% | 1827 |
|
Other funds holding IMGN
RG
RCM
FFM
Stifel Financial's IMGN Position: Q3 2023 in Review
Stifel Financial sold out of Immunogen Inc (IMGN) in Q3 2023, closing a stake of 11,601 shares — an estimated $219K sold.
Stifel Financial first reported a position in IMGN in Q2 2015 and held it in 33 quarters. The position peaked at $968K in Q4 2015. 275 funds tracked by Wall St. Rank hold IMGN as of Q3 2023.
- Stifel Financial reported no remaining Immunogen Inc position as of Q3 2023 after selling out during the quarter.
- Stifel Financial sold 11,601 Immunogen Inc shares in Q3 2023, an estimated $219K.
- Stifel Financial first reported a position in Immunogen Inc in Q2 2015 and held it in 33 quarters.
- Stifel Financial's Immunogen Inc position peaked at $968K in Q4 2015.
- 275 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2023.
Based on Stifel Financial's 13F filing for Q3 2023, filed 13 Nov 2023.